Mitonafide
Alternative Names: M 4212; NSC 300288Latest Information Update: 05 Feb 2013
At a glance
- Originator Abbott GmbH & Co. KG
- Class Antineoplastics
- Mechanism of Action DNA synthesis inhibitors; RNA synthesis inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer